The Clinical Relevance of Multidrug Resistance

References

• Chabner B A, Fine R L, Allegra C J, et al. Cancer chemotherapy: progress and expectations. Cancer 1984; 54: 2599–2608
   PubMedGoogle Scholar
• Goldie J H, Coldman A J. Genetic instability in the development of drug resistance. Semin Oncol 1985; 12: 222–230
   PubMed Web of Science ®Google Scholar
• Lauria S E, Delbruck M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943; 28: 491–511
   PubMedGoogle Scholar
• Law L W. Origin of the resistance of leukaemic cells to folic acid antagonists. Nature 1952; 169: 628–629
   PubMed Web of Science ®Google Scholar
• Goldie J, Coldman A J. The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res 1984; 44: 3643–3653
   PubMed Web of Science ®Google Scholar
• Siminovitch L. On the nature of heritable variation in cultured somatic cells. Cell 1976; 7: 1–11
   PubMed Web of Science ®Google Scholar
• Goldie J H, Coldman A J. Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat Rep 1983; 67: 923–931
   PubMedGoogle Scholar
• Ling V. Genetic basis of drug resistance in mammalian cells. Drug and Hormone Resistance in Neoplasia, N Bruchovsky, J H Goldie. CRC Press, Boca Raton, FL 1982; vol. 1.: 1–19
   Google Scholar
• Tannock I. Tumor growth and kinetics. The Basic Science of Oncology, I Tannock, R Hill. Pergamon Press, New York 1987; 140–159
   Google Scholar
• Buick R. The cell renewal hierarchy in ovarian cancer. Human Tumor Cloning, S E Salmon, J M Trent. Grune & Stratton, Orlando 1984; 3–13
   Google Scholar
• Kessel D, Botterill V, Wodinsky I. Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. Cancer Res 1968; 28: 938–941
   PubMed Web of Science ®Google Scholar
• Kessel D, Hall T C, Roberts D, et al. Uptake as a determinant of methotrexate response in mouse leukemia. Science 1965; 150: 752–754
   PubMed Web of Science ®Google Scholar
• Biedler J L, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 1970; 30: 1174–1184
   PubMed Web of Science ®Google Scholar
• Bech-Hansen N T, Till J E, Ling V. Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity. J Cell Physiol 1976; 88: 23–32
   PubMed Web of Science ®Google Scholar
• Ling V, Thompson L H. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 1974; 83: 103–116
   PubMed Web of Science ®Google Scholar
• Carlsen S A, Till J E, Ling V. Modulation of drug permeability in Chinese hamster ovary cells: possible role for phosphorylation of surface glycoproteins. Biochem Biophys Acta 1977; 467: 238–250
   PubMed Web of Science ®Google Scholar
• Juliano R L, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 1976; 455: 152–162
   PubMed Web of Science ®Google Scholar
• Kartner N, Rordan J R, Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 1983; 221: 1285–1288
   PubMed Web of Science ®Google Scholar
• Harker W, Sikic B I. Multidrug (pleiotropic) resistance to doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res 1985; 45: 4091–4096
   PubMed Web of Science ®Google Scholar
• Dalton W S, Durie B GM, Alberts D S, et al. Characterization of a new drug-resistant human myeloma cell line that expresses P glycoprotein. Cancer Res 1986; 46: 5125–5130
   PubMed Web of Science ®Google Scholar
• Beck W T, Mueller T J, Tanzer L R. Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 1979; 39: 2070–2076
   PubMed Web of Science ®Google Scholar
• Howell N, Belli T A, Zaczkiewicz L T, et al. High-level, unstable adriamycin resistance in a Chinese hamster mutant cell line with double minute chromosomes. Cancer Res 1984; 44: 4023–4029
   PubMed Web of Science ®Google Scholar
• Akiyama S, Fojo A, Hanover J A, et al. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Md Gen 1985; 11: 117–126
   PubMed Web of Science ®Google Scholar
• Kartner N, Evemden-Porelle D, Bradley G, et al. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1985; 316: 820–823
   PubMed Web of Science ®Google Scholar
• Shen D., Cardarelli C, Hwang J, et al. Multiple drug-resistant human KB carcinoma cells independently selected for high level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 1986; 261: 7762–7770
   PubMed Web of Science ®Google Scholar
• Twentyman P R, Fox N E, Wright K A, et al. Derivation and preliminary characterization of adriamycin resistant lines of human lung cancer cells. Br J Cancer 1986; 53: 529–537
   PubMed Web of Science ®Google Scholar
• Diddens H, Gekeler V, Neumann M, et al. Characterization of actinomycin-D-resistant CHO cell lines exhibiting a multidrug-resistance phenotype and amplified DNA sequences. Int J Cancer 1987; 40: 635–642
   PubMed Web of Science ®Google Scholar
• Dorr R T, Liddil J D, Trent J, et al. Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistance. Biochem Pharm 1987; 36: 3115–3120
   PubMed Web of Science ®Google Scholar
• Ganapathi R, Grabowski D, Schmidt H, et al. Characterization in vitro and in vivo of progressively adriamycin-reistant B16-BL6 mouse melanoma cells. Cancer Res 1987; 47: 3464–3468
   PubMed Web of Science ®Google Scholar
• Panneerselvam M, Bredehorst R, Vogel C. Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicin. Cancer Res 1987; 47: 4601–4607
   PubMed Web of Science ®Google Scholar
• Beck W T, Cirtain M C, Danks M K, et al. Pharmacological, molecular, and cytogentic analysis of “atypical” multidrug-resistant human leukemic cells. Cancer Res 1987; 47: 5455–5460
   PubMed Web of Science ®Google Scholar
• Danks M K, Yalowich J C, Beck W T. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Res 1987; 47: 1297–1301
   PubMed Web of Science ®Google Scholar
• Mirski S EL, Gerlach J H, Cole S P. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res 1987; 47: 2594–2598
   PubMed Web of Science ®Google Scholar
• Dalton W S, Cress A E, Alberts D S, et al. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Cancer Res 1988; 48: 1882–1888
   PubMed Web of Science ®Google Scholar
• Riordan J R, Deuchars K, Kartner N, et al. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 1985; 316: 817–819
   PubMed Web of Science ®Google Scholar
• Fojo A T, Whang-Peng J, Gottesman M M, et al. Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci (USA) 1985; 82: 7661–7665
   PubMed Web of Science ®Google Scholar
• Gros P, Croop J, Roninson I, et al. Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc Natl Acad Sci (USA) 1986; 83: 337–341
   PubMed Web of Science ®Google Scholar
• Scotto K W, Biedler I L, Malera P W. Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science 1986; 232: 751–755
   PubMed Web of Science ®Google Scholar
• Roninson I B, Abelson H T, Housman D E, et al. Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells. Nature 1984; 309: 626–628
   PubMed Web of Science ®Google Scholar
• Meyers M B, Spengler B A, Chang T, et al. Gene amplification-associated cytogenetic aberrations and protein changes in vincristine-resistant Chinese hamster, mouse, and human cells. J Cell Biol 1985; 100: 588–597
   PubMed Web of Science ®Google Scholar
• Van der Bliek A M, Meyers M B, Biedler J L, et al. A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain. EMBO J 1986; 5: 3201–3208
   PubMed Web of Science ®Google Scholar
• Van der Bliek A M, Van der Velde-Koerts T, Lind V, et al. Overexpression and amplification of five genes in a multidrug resistant Chinese hamster ovary cell line. Mol Cell Biol 1986; 6: 1671–1678
   PubMed Web of Science ®Google Scholar
• Ueda K, Cornwell M M, Gottesman M M, et al. The mdr1 gene, responsible for multidrug-resistance, codes for the p-glycoprotein. Biochem Biophys Res Comm 1986; 141: 956–962
   PubMed Web of Science ®Google Scholar
• Ueda K, Cardarelli C, Gottesman M M, et al. Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci (USA) 1987; 84: 3004–3008
   PubMed Web of Science ®Google Scholar
• Guild B C, Mulligan R C, Gros P, et al. Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection. Proc Natl Acad Sci (USA) 1988; 85: 1595–1599
   PubMed Web of Science ®Google Scholar
• Ng W, Sarangi F, Zastawny R, et al. The hamster P-glycoprotein gene family contains three members: pgp 1, pgp2, and pgp3. Proc AACR 1988; 29: 308
   Google Scholar
• Gros P, Raymond M., Bell J, et al. Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol 1988; 8: 2770–2778
   PubMed Web of Science ®Google Scholar
• Choi K, Chen C, Kriegler M, et al. An altered pattern of cross-resistance in multidrug resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell 1988; 53: 519–529
   PubMed Web of Science ®Google Scholar
• Van der Bliek A M, Baas F, Houte de Lange T T, et al. The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J 1987; 6: 3325–3331
   PubMed Web of Science ®Google Scholar
• Shen D, Fojo A, Roninson I B, et al. Multidrug resistance of DNA-mediated trans-formants is linked to transfer of the human mdr1 gene. Mol Cell Biol 1986; 6: 4039–4044
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Roninson I B, Tsuruo T. Decreased expression of the amplified mdr1 gene in revertants of multidrug-resistant human myelogenous leukemia K5662 occurs without loss of amplified DNA. Mol cell Biol 1987; 7: 4549–4552
   PubMed Web of Science ®Google Scholar
• Gros P, Croop J, Houseman D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 1986; 47: 371–380
   PubMed Web of Science ®Google Scholar
• Chen C, Chin J E, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (p-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381–389
   PubMed Web of Science ®Google Scholar
• Gerlach J H, Endicott J A, Juranka P F, et al. Homology between p-glycoprotein and a bacterial haemorysin transport protein suggests a model for multidrug resistance. Nature 1986; 324: 485–489
   PubMed Web of Science ®Google Scholar
• Beck W T, Cirtain M C. Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase. Cancer Res 1982; 42: 184–189
   PubMed Web of Science ®Google Scholar
• Willingham M C, Richert N D, Cornwell M M, et al. Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells. J Histochem Cytochem 1987; 35: 1451–1456
   PubMed Web of Science ®Google Scholar
• Fojo A T, Ueda K M, Slamon D J, et al. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Nati Acad Sci (USA) 1987; 84: 265–269
   PubMed Web of Science ®Google Scholar
• Sugawara I, Katakoa I, Morishita Y, et al. Tissue distribution of p-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK16. Cancer Res 1988; 48: 1926–1929
   PubMed Web of Science ®Google Scholar
• Sugawara I, Nakahama M, Hamada H, et al. Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000–180,000 P-glycoprotein. Cancer Res 1988; 48: 4611–4614
   PubMed Web of Science ®Google Scholar
• Kessel D, Bosmann H B. On the characteristics of actinomycin D resistance in L5178Y cells. Cancer Res 1970; 30: 2695–2701
   PubMed Web of Science ®Google Scholar
• Riehm H, Biedler J L. Cellular resistance to daunomycin in Chinese hamster cells in vitro. Cancer Res 1971; 31: 409–412
   PubMed Web of Science ®Google Scholar
• Dano K. Active outward transport of daunomycin in resistant ehrlich ascites tumor cells. Biochem Biophys Acta 1973; 323: 466–483
   PubMed Web of Science ®Google Scholar
• Inaba M, Johnson R K. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia. Cancer Res 1977; 37: 4629–4634
   PubMed Web of Science ®Google Scholar
• Skovsgaard T. Mechanisms of resistance to daunorubicin in ehrlich ascites tumor cells. Cancer Res 1978; 38: 1785–1791
   PubMed Web of Science ®Google Scholar
• Fojo A, Akiyama S, Gottesman M M, et al. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res 1985; 45: 3002–3007
   PubMed Web of Science ®Google Scholar
• Inaba M, Fujikura R, Sakuri Y. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia. Biochem Pharm 1981; 30: 1863–1865
   PubMed Web of Science ®Google Scholar
• Inaba M, Sakuri Y. Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia. Cancer Lett 1979; 8: 111–115
   PubMed Web of Science ®Google Scholar
• Debenham P C, Kartner N, Siminovitch L, et al. DNA-mediated transfer of multiple drug resistance and palsma membrane glycoprotein expression. Mol Cell Biol 1982; 2: 881–889
   PubMed Web of Science ®Google Scholar
• Deuchars K L, Du R, Naik M, et al. Expression of hamster p-glycoprotein and multiple drug resistance in DNA-mediated transformants of mouse LTA cells. Mol Cell Biol 1987; 7: 718–724
   PubMed Web of Science ®Google Scholar
• Gros P, Neriah Y B, Croop J M, et al. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 1986; 323: 728–731
   PubMed Web of Science ®Google Scholar
• Pastan I, Gottesman M M, Veda K, et al. A retrovirus carrying an MDR1 DNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci (USA) 1988; 85: 4486–4490
   PubMed Web of Science ®Google Scholar
• Cornwell M M, Safa A R, Felsted R L, et al. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150-to 170-kDa protein detected by photoaffinity labeling. Proc Natl Acad Sci (USA) 1986; 83: 3847–3850
   PubMed Web of Science ®Google Scholar
• Cornwell M M, Gottesman M M, Pastan I H. Increased vinblastine binding to membrane vesicles from multidnig-resistant KB cells. J Biol Chem 1986; 261: 7921–7928
   PubMed Web of Science ®Google Scholar
• Safa A H, Glover C J, Meyers M B, et al. Vinblastine photoaffinity labeling of a specific for multidnig-resistant cells. J Biol Chem 1986; 261: 6137–6140
   PubMed Web of Science ®Google Scholar
• Safa A R, Glover C J, Sewell J L, et al. Identification of the multi-drug resistance-related membrane glycoprotein as an acceptor for calcium channel Mockers. J Biol Chem 1987; 262: 7884–7888
   PubMed Web of Science ®Google Scholar
• Yang C H, Mellado W, Horwitz S B. Azidopine photoaffinity labeling of multidrug resistance-associated grycoproteins. Biochem Pharm 1988; 37: 1417–1421
   PubMed Web of Science ®Google Scholar
• Garman D, Albers L, Center M S. Identification and characterization of a plasma membrane phosphoprotein which is present in Chinese hamster lung cells resistant to adriamycin. Biochem Pharm 1983; 32: 3633–3637
   PubMed Web of Science ®Google Scholar
• Garman D, Center M S. Alterations in cell surface membranes in Chinese hamster lung cells resistant to adriamycin. Biochem Biophys Res Comm 1982; 105: 157–163
   PubMed Web of Science ®Google Scholar
• Peterson R HF, Meyers M B, Spengler B A, et al. Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine. Cancer Res 1983; 43: 222–228
   PubMed Web of Science ®Google Scholar
• Richert N, Akiyama S, Shen D, et al. Multiply drug-resistant human KB carcinoma cells have decreased amounts of a 75-kDa and a 72-kDa glycoprotein. Proc Natl Acad Sci (USA) 1985; 82: 2330–2333
   PubMed Web of Science ®Google Scholar
• Marsh W, Center M S. Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells. Cancer Res 1987; 47: 5080–5086
   PubMed Web of Science ®Google Scholar
• Marsh W, Center M S. Evidence for the involvement of two distinct membrane proteins in adiramycin resistance in Chinese hamster lung cells. Cancer Res 1985; 45: 6088–6092
   PubMed Web of Science ®Google Scholar
• Meyers M B, Biedler J L. Increased synthesis of a low molecular weight protein in vincristine-resistant cells. Biochem Biophys Res Comm 1981; 99: 228–235
   PubMed Web of Science ®Google Scholar
• Biedler J L, Chang T, Meyers M B, et al. Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat Rep 1983; 67: 859–867
   PubMedGoogle Scholar
• Meyers M B, Merluzzi V J, Spengler B A, et al. Epidermal growth factor receptor is increased in multidnig-resistant Chinese hamster and mouse tumor cells. Proc Natl Acad Sci (USA) 1986; 83: 5521–5525
   PubMed Web of Science ®Google Scholar
• Reeve J G, Koch G LE, Twentyman P R. Evidence that multidrug resistance in Chinese hamster ovary cells is associated with alterations in the endoplasmic reticuhim. Br J Cancer 1987; 56: 143–145
   PubMed Web of Science ®Google Scholar
• Sugawara I, Ohkochi E, Hamada H, et al. Cellular and tissue distribution of MRK20 murine monoclonal antibody-defined 85-kDa protein in adriamycin-resistant cancer cell lines. Jpn J Cancer Res (Gann) 1988; 79: 1101–1110
   PubMedGoogle Scholar
• Slovak M L, Hoeltge G A, Dalton W S, et al. Pharmacologic and biological evidence for differing mechanisms of doxorubicin resistance in two human cell lines. Cancer Res 1988; 48: 2793–2797
   PubMed Web of Science ®Google Scholar
• Arrick B A, Nathan C F. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res 1984; 44: 4224–4232
   PubMed Web of Science ®Google Scholar
• Batist G, Tulpule A, Sinha B K, et al. Overexpression of a novel anionic glutathione transferase in multidnig-resistant human breast cancer cells. J Biol Chem 1986; 261: 15544–15549
   PubMed Web of Science ®Google Scholar
• Mannervik B. The isoenzymes of glutathione transferase. Adv Enzymol Reg 1985; 57: 357–417
   PubMedGoogle Scholar
• Moscow J A, Townsend A J, Baird W M, et al. Transfection of a vector expressing the human anionic glutathione-S-transferase confers resistance to alkylating agents. Proc AACR 1988; 29: 314
   Google Scholar
• Bellamy W T, Dalton W S, Meltzer P, et al. The role of glutathione and its associated enzymes in multidrug resistant human myeloma cells. Biochem Pharm 1989; 38: 787–793
   PubMed Web of Science ®Google Scholar
• Di Ilio C, Sacchetta P, Del Boccio G, et al. Glutathione peroxidase, glutathione S-transferase and glutathione reductase activities in normal and neoplastic human breast tissue. Cancer Lett 1985; 29: 37–42
   PubMed Web of Science ®Google Scholar
• Yusa K, Hamada H, Tsuruo T. Comparison of glutathione S-transferase activity between drug-resistant and -sensitive human tumor cells: Is glutathione S-transferase associated with multidrug resistance?. Cancer Chemother Pharmacol 1988; 22: 17–20
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Iida H, Tsukagoshi S, et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981; 41: 1967–1972
   PubMed Web of Science ®Google Scholar
• Akiyama S, Cornwell M M, Kuwano M, et al. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of p-glycoprotein by a vinblastine analog. Mol Pharm 1988; 33: 144–147
   PubMed Web of Science ®Google Scholar
• Klohs W D, Steinkampf R W. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in drug-resistant cells. Mol Pharm 1988; 34: 180–185
   Web of Science ®Google Scholar
• Nair S, Anantha Samy T S, Krishan A. Calcium calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells. Cancer Res 1986; 46: 229–232
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Iida H, Kitatani Y, et al. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res 1984; 44: 4303–4307
   PubMed Web of Science ®Google Scholar
• Kessel D, Wilberding C. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists. Cancer Res 1985; 45: 1687–1691
   PubMed Web of Science ®Google Scholar
• Ramu A, Spanier R, Rahaminoff H, et al. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells. Br J cancer 1984; 50: 501–507
   PubMed Web of Science ®Google Scholar
• Bellamy W T, Dorr R T, Dalton W S, et al. Direct relations of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration. Cancer Res 1988; 48: 6360–6364
   PubMed Web of Science ®Google Scholar
• Bellamy W T, Dalton W S, Kailey J M, et al. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage. Cancer Res 1988; 48: 6365–6370
   PubMed Web of Science ®Google Scholar
• Akiyama S, Tomita K, Kuwano M. The effect of calcium antagonists on the proteolytic degradation of low-density lipoprotein in HeLa cells. Exp Cell Res 1985; 158: 192–204
   PubMed Web of Science ®Google Scholar
• Shiraishi N, Akiyama S, Kobayshi M, et al. Lysosomotropic agents reverse multiple drug resistance in human cancer cells. Cancer Lett 1986; 30: 251–259
   PubMed Web of Science ®Google Scholar
• Zamora J M, Beck W T. Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells. Biochem Pharm 1986; 35: 4304–4310
   Google Scholar
• Hindenburg A A, Baker M A, Gleyzer E, et al. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res 1987; 47: 1421–1425
   PubMed Web of Science ®Google Scholar
• Harker W G, Bauer D, Etiz B B, et al. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA strand scission. Cancer Res 1986; 46: 2369–2372
   PubMed Web of Science ®Google Scholar
• Beck W T, Cirtain M C, Look A T, et al. Reversal of vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil. Cancer Res 1986; 46: 778–784
   PubMed Web of Science ®Google Scholar
• Delaporte C, Charcosset J, Jacquemin-Sablon A. Effects of verapamil on the cellular accumulations and toxicity of several antitumor drugs in 9-hydroxy-ellipticine-resistant cells. Biochem Pharm 1988; 37: 613–619
   PubMed Web of Science ®Google Scholar
• Chauffert B, Rey D, Coudert B, et al. Amiodarone is more efficient than verapamil in reversing resistance ot anthracyclines in tumour cells. Br J Cancer 1987; 56: 119–122
   PubMed Web of Science ®Google Scholar
• Ganapathi R, Grabowski D, Turinic R, et al. Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (Adriamycin) in resistant P388 mouse leukemia cells. Eur J Cancer Clin Oncol 1984; 20: 799–806
   PubMedGoogle Scholar
• Twentyman P R, Fox N E, White D JG. Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer 1987; 56: 55–57
   PubMed Web of Science ®Google Scholar
• Ramu A, Fuks Z, Gatt S, et al. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. Cancer Res 1984; 44: 144–148
   PubMed Web of Science ®Google Scholar
• Ramu A, Glaugiber D, Fuks Z. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res 1984; 44: 4392–4395
   PubMed Web of Science ®Google Scholar
• Ganapathi R, Garbowski D. Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Biochem Pharm 1988; 37: 185–193
   PubMed Web of Science ®Google Scholar
• Riehm H, Biedler J L. Potentiation of drug effect by tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res 1972; 32: 1195–1200
   PubMed Web of Science ®Google Scholar
• Slater L M, Murray S L, Wetzel M W, et al. Verapamil potennation of VP-16–213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance. Cancer Chemother Pharm 1986; 16: 50–54
   PubMed Web of Science ®Google Scholar
• Rogan A M, Hamilton T C, Young R C, et al. Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science 1984; 224: 994–996
   PubMed Web of Science ®Google Scholar
• Bell D R, Gerlach J H, Kartner N, et al. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol 1985; 3: 311–315
   PubMed Web of Science ®Google Scholar
• Gerlach J H, Bell D R, Karakousis C, et al. P-glycoprotein in human sarcoma: evident for multidrug resistance. J Clin Oncol 1987; 5: 1452–1460
   PubMed Web of Science ®Google Scholar
• Ma D DF, Davey R A, Harman D H, et al. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet 1987; 1: 135–137
   PubMed Web of Science ®Google Scholar
• Bell D R, Friedlander M L, Young G, et al. P-glycoprotein expression in clinically drug-resistant hematologic malignancies. Proc ASCO 1988; 7: 175
   Google Scholar
• Carulli G, Petrnin M, Marini A, et al. P-glycoprotein in acute nonlymphoblastic leukemia and in the blastic crisis of myeloid leukemia. N Engl J Med 1988; 319: 797–798
   PubMed Web of Science ®Google Scholar
• Dalton W S, Grogan T M, Rybski J A, et al. Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug resistant human myeloma cells: association with level of drug resistance and drug accumulation. Blood 1989; 73: 747–752
   PubMed Web of Science ®Google Scholar
• Dalton W S, Grogan T M, Meltzer P S, et al. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 1989; 7: 415–424
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Sugimoto Y, Hamada H, et al. Detection of multidrug resistance markers, P-glycoprotein and mdr-1 mRNA, in human leukemia cells. Jpn J Cancer Res (Gann) 1987; 78: 1415–1419
   PubMedGoogle Scholar
• Champlin R E, Golde D W. Chronic myelogenous leukemia: recent advances. Blood 1987; 65: 1039–1047
   Web of Science ®Google Scholar
• Kakehi Y, Kanamanu H, Yoshida O, et al. Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance. J Urol 1988; 139: 862–865
   PubMed Web of Science ®Google Scholar
• Berry J M, Brophy N A, Smith S D, et al. Increased expression of the multidrug resistance gene mdr 1 in human cancers. Proc ASCO 1988; 7: 51
   Google Scholar
• Goldstein L J, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116–124
   PubMed Web of Science ®Google Scholar
• Benson A B, Trump D L, Koeller J M, et al. Phase I study of vinblastine and verapamil given by concurrert IV infusion. Cancer Treat Rep 1985; 69: 795–799
   PubMedGoogle Scholar
• Present C A, Kennedy P S, Wiseman C, et al. Verapamil reversal of clinical doxorubicin resistance in human cancer. Am J Clin Oncol (CCT) 1986; 9: 355–357
   PubMed Web of Science ®Google Scholar
• Ozols R F, Cunnion R E, Klecker R W, et al. Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol 1987; 5: 641–647
   PubMed Web of Science ®Google Scholar
• Zipes D P, Prystowsky E N, Heger J J. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol 1984; 3: 1059–1071
   PubMed Web of Science ®Google Scholar
• Figueredo A, Arnold A, Findlay B, et al. Pilot study of verapamil and tamoxifen added to chemotherapy of extensive small cell lung cancer. Proc AACR 1988; 29: 208
   Google Scholar
• Wheeler H, Bell D, Levi J. A randomized study of doxorubicin, etoposide, and vindesine with or without verapamil, in small cell lung cancer. Proc AACR 1988; 29: 208
   Google Scholar
• Moran E M, Nagourney R A, Ottenheimer E J, et al. Reversal of acquired drug resistance with lidocaine and verapamil: A phase I study. Proc AACR 1988; 29: 218
   Google Scholar